Skip to main content
. 2023 Oct 19;15(10):2490. doi: 10.3390/pharmaceutics15102490
NPs nanoparticles
EPR enhanced permeability and retention effect
PEG polyethylene glycol
TME tumor microenvironment
OMVs outer membrane vesicles
DMVs bilayer membrane vesicles
BMVs bacterial membrane vesicles
BGs bacterial ghosts
BSPs bacterial spores
E. coli Escherichia coli
EcN E. coli Nissle 1917
S. boulardii Saccharomyces boulardii
L. reuteri Lactobacillus reuteri
L. casei Lactobacillus casei
L. rhamnosus Lactobacillus rhamnosus
L. m Listeria monocytogenes
LA Lactobacillus acidophilus
B. infantis Bifidobacterium infantis
B. breve Bifidobacterium breve
BB Bifidobacterium bifidum
LPS lipopolysaccharide
TNF-α tumor necrosis factor-α
IL-6 interleukin-6
IL-β interleukin-β
EOMVs explosive outer membrane vesicles
OIMVs outer inner membrane vesicles
CMVs cytoplasmic membrane vesicles
PAMPs pathogen-associated molecular patterns
DC dendritic
αPD-1 Anti-programmed death-1
PD-1 programmed death-1
PTT photothermal therapy
ClyA cytolysin
RBC red blood cell
TLR4 toll-like receptor 4
MDR multidrug resistance
DOX doxorubicin
RGD Arg-Gly-Asp
COVID-19 coronavirus disease-19
PDA polydopamine
OVA ovalbumin antigen
HSA human serum albumin
LDH layered-double-hydroxide
NIR near-infrared
PLGA Poly (lactic-co-glycolic acid)
5-FU 5-fluorouracil
BBB blood–brain barrier
BCG Bacillus Calmette-Guerin